• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性出血性疾病的出血评分:临床工具还是研究工具?

Bleeding scores in inherited bleeding disorders: clinical or research tools?

作者信息

Tosetto A, Castaman G, Rodeghiero F

机构信息

Hematology Department, S. Bortolo Hospital, Vicenza, Italy.

出版信息

Haemophilia. 2008 May;14(3):415-22. doi: 10.1111/j.1365-2516.2007.01648.x. Epub 2008 Jan 21.

DOI:10.1111/j.1365-2516.2007.01648.x
PMID:18218013
Abstract

The diagnosis of bleeding disorders is strictly dependent on the presence of bleeding symptoms in the patient, but collection of the bleeding history and its interpretation still remains subjective. For this reason, questionnaires on bleeding history have been proposed, and validated as diagnostic tools by comparing data obtained from patients with normal controls. This effort had led, at least with respect to von Willebrand disease (VWD), to the establishment of criteria that allow discrimination of VWD carriers from normal subjects. Among the possible criteria, a promising one is represented by the bleeding score (BS), a quantitative index summarizing both the number of episodes and their severity. The BS has shown good sensitivity and specificity for the diagnosis of type 1 VWD and could be integrated in a full diagnostic algorithm that also accounts for laboratory and family data. Furthermore, the BS has been shown to be correlated with several biological variables, including VWF and FVIII:C levels, platelet function analyzer (PFA-100) closure times, and platelet glycoprotein haplotypes. Thus, collection of the BS at the time of the diagnosis may be a useful addition in the evaluation of the bleeding patients for both the researcher and medical practitioner, although the latter should probably wait for the results of further validation studies before making more extensive use of BS as a diagnostic tool.

摘要

出血性疾病的诊断严格依赖于患者出血症状的存在,但出血病史的收集及其解读仍然具有主观性。因此,有人提出了关于出血病史的问卷,并通过将患者数据与正常对照者的数据进行比较,验证其作为诊断工具的有效性。至少就血管性血友病(VWD)而言,这一努力导致了能够区分VWD携带者与正常受试者的标准的建立。在可能的标准中,一个有前景的标准是出血评分(BS),这是一个综合发作次数及其严重程度的定量指标。BS对1型VWD的诊断显示出良好的敏感性和特异性,并且可以纳入一个完整的诊断算法中,该算法还考虑实验室和家族数据。此外,BS已被证明与几个生物学变量相关,包括血管性血友病因子(VWF)和凝血因子VIII:C水平、血小板功能分析仪(PFA-100)的封闭时间以及血小板糖蛋白单倍型。因此,在诊断时收集BS对于研究人员和医生评估出血患者可能是一个有用的补充,尽管后者在更广泛地将BS用作诊断工具之前,可能应该等待进一步验证研究的结果。

相似文献

1
Bleeding scores in inherited bleeding disorders: clinical or research tools?遗传性出血性疾病的出血评分:临床工具还是研究工具?
Haemophilia. 2008 May;14(3):415-22. doi: 10.1111/j.1365-2516.2007.01648.x. Epub 2008 Jan 21.
2
Assessing bleeding in von Willebrand disease with bleeding score.使用出血评分评估血管性血友病的出血情况。
Blood Rev. 2007 Mar;21(2):89-97. doi: 10.1016/j.blre.2006.04.002. Epub 2006 Jun 13.
3
Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.血小板血管性血友病因子测定并不能改善疑似1型血管性血友病患者的诊断。
Haemophilia. 2009 Jan;15(1):131-4. doi: 10.1111/j.1365-2516.2008.01904.x. Epub 2008 Oct 23.
4
Laboratory diagnosis and molecular classification of von Willebrand disease.血管性血友病的实验室诊断与分子分类
Acta Haematol. 2009;121(2-3):71-84. doi: 10.1159/000214846. Epub 2009 Jun 8.
5
Relevance of quantitative assessment of bleeding in haemorrhagic disorders.出血性疾病中出血定量评估的相关性
Haemophilia. 2008 Jul;14 Suppl 3:68-75. doi: 10.1111/j.1365-2516.2008.01714.x.
6
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).血管性血友病(VWD):基于证据的诊断和管理指南,美国国立心肺血液研究所(NHLBI)专家小组报告
Haemophilia. 2008 Mar;14(2):171-232. doi: 10.1111/j.1365-2516.2007.01643.x.
7
The spectrum of inherited bleeding disorders in pediatrics.儿科遗传性出血性疾病的谱系
Blood Coagul Fibrinolysis. 2008 Dec;19(8):771-5. doi: 10.1097/MBC.0b013e32830f1b99.
8
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.1型/2E型(2A亚型IIE)血管性血友病、1型维琴察型血管性血友病以及由血管性血友病因子基因的D3、D4、B1 - B3和C1 - C2结构域突变引起的轻型1型血管性血友病的实验室诊断。血管性血友病因子多聚体及血管性血友病因子前肽/抗原比值的作用。
Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8.
9
The condensed MCMDM-1 VWD bleeding questionnaire as a predictor of bleeding disorders in women with unexplained menorrhagia.简明MCMDM-1 VWD出血问卷作为不明原因月经过多女性出血性疾病的预测指标。
Blood Coagul Fibrinolysis. 2012 Jun;23(4):311-5. doi: 10.1097/MBC.0b013e32835274d9.
10
Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?血小板型血管性血友病的表型鉴定及其与2B型血管性血友病的鉴别:是2B型还是非2B型的问题?非同卵双胞胎的故事?还是多因素或多层面的初级止血这枚硬币的两面?
Semin Thromb Hemost. 2008 Feb;34(1):113-27. doi: 10.1055/s-2008-1066019.

引用本文的文献

1
Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes.非重度血友病:需要重新聚焦并改善治疗结果。
Semin Thromb Hemost. 2025 Feb;51(1):58-67. doi: 10.1055/s-0044-1786358. Epub 2024 May 11.
2
Glanzmann Thrombasthenia in Pakistani Patients: Identification of 7 Novel Pathogenic Variants in the Fibrinogen Receptor αIIbβ3.巴基斯坦患者的 Glanzmann 血小板无力症:纤维蛋白原受体 αIIbβ3 中的 7 种新型致病性变异的鉴定。
Cells. 2023 Jan 4;12(2):213. doi: 10.3390/cells12020213.
3
Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotype.
3 型血管性血友病患者和有严重出血表型的患者社会参与度降低。
Haemophilia. 2022 Mar;28(2):278-285. doi: 10.1111/hae.14475. Epub 2021 Dec 29.
4
Von Willebrand disease type 2M: Correlation between genotype and phenotype.血管性血友病 2M 型:基因型与表型的相关性。
J Thromb Haemost. 2022 Feb;20(2):316-327. doi: 10.1111/jth.15586. Epub 2021 Nov 21.
5
Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms.预测血管性血友病的出血评估工具:个体出血症状的效用
Res Pract Thromb Haemost. 2019 Oct 30;4(1):92-99. doi: 10.1002/rth2.12256. eCollection 2020 Jan.
6
von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD.去氨加压素治疗后 von Willebrand 因子和因子 VIII 水平与 1 型血管性血友病的出血表型相关。
Blood Adv. 2019 Dec 23;3(24):4147-4154. doi: 10.1182/bloodadvances.2019000863.
7
Assessment of Patients with von Willebrand Disease with ISTH/BAT and PBQ Scores.使用国际血栓与止血学会(ISTH)/血管性血友病因子活性检测(BAT)评分和血小板功能检测(PBQ)评分对血管性血友病患者进行评估。
Turk J Haematol. 2020 Feb 20;37(1):57-58. doi: 10.4274/tjh.galenos.2019.2019.0446. Epub 2019 Nov 13.
8
How I manage severe von Willebrand disease.我是如何管理严重的血管性血友病的。
Br J Haematol. 2019 Nov;187(4):418-430. doi: 10.1111/bjh.16186. Epub 2019 Sep 9.
9
Sports participation and physical activity in patients with von Willebrand disease.血管性血友病患者的运动参与和体育活动。
Haemophilia. 2019 Jan;25(1):101-108. doi: 10.1111/hae.13629. Epub 2018 Nov 14.
10
Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease.与较高 von Willebrand 因子 (VWF) 水平相关的合并症可能解释了 von Willebrand 病中 VWF 随年龄增长而增加的原因。
Br J Haematol. 2018 Jul;182(1):93-105. doi: 10.1111/bjh.15277. Epub 2018 May 16.